"Hays Medical Center is a private, not-for-profit hospital formed by the 1991 merger of two religiously affiliated facilities, and provides the only tertiary level services in the region. The organization’s mission to “To Help People Be Healthy. HaysMed is part of The University of Kansas Health System."

During the past decade, HaysMed University of Kansas Health System conducted 101 clinical trials. In the 10-year time frame, 101 clinical trials started and 65 clinical trials were completed, i.e. on average, 64.4% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 39 clinical trials were completed. i.e. 88.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HaysMed University of Kansas Health System" #1 sponsor was "National Cancer Institute (NCI)" with 83 trials, followed by "SWOG Cancer Research Network" with 41 trials sponsored, "Alliance for Clinical Trials in Oncology" with 16 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "NRG Oncology" with 5 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HaysMed University of Kansas Health System" #1 collaborator was "National Cancer Institute (NCI)" with 68 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "HaysMed University of Kansas Health System" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (9 trials), "Invasive Breast Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Recurrent Melanoma" (6 trials). Many other conditions were trialed in "HaysMed University of Kansas Health System" in a lesser frequency.

Most popular intervention types in "HaysMed University of Kansas Health System" are "Drug" (123 trials), "Other" (87 trials), "Biological" (71 trials), "Procedure" (44 trials) and "Radiation" (14 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (43 trials), "Quality-of-Life Assessment" (29 trials), "Biospecimen Collection" (27 trials), "Computed Tomography" (25 trials) and "Nivolumab" (19 trials). Other intervention names were less common.

The vast majority of trials in "HaysMed University of Kansas Health System" are 134 trials for "All" genders, 13 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "HaysMed University of Kansas Health System". undefined are not yet recruiting, 32 are recruiting, 85 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in HaysMed University of Kansas Health System, 3 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in HaysMed University of Kansas Health System, 11 "Phase 1" clinical trials were conducted, 83 "Phase 2" clinical trials and 67 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

HaysMed University of Kansas Health System has several departments that took part in Clinical trials: "Hays Medical Center Dreiling-Schmidt Cancer Institute" - 2 trials